239 - ICH Q11 in 6 Minutes

239 - ICH Q11 in 6 Minutes

In this episode, Subhi breaks down Q11 by focusing on three key sections: how the drug substance process is developed, where that process begins, and how it is controlled.


He places Q11 in context with Q7 for API GMP, Q8 for pharmaceutical development, Q9 for quality risk management, and Q10 for the pharmaceutical quality system. The episode covers Section 3 on manufacturing process development, Section 5 on starting materials, and Section 6 on control strategy beyond release testing.


In the next episode, Subhi will cover ICH Q12.


Timestamps

00:00 ICH Q11 overview

00:47 Drug substance basics

01:14 Where Q11 fits in the ICH Quality framework

02:15 Section 3: Manufacturing process development

03:26 Linking drug substance quality to drug product quality

04:25 Section 5: Starting materials

05:41 Section 6: Control strategy

06:11 Wrap-up and next episode


Subhi Saadeh is the Founder and Principal at Let’s Combinate, where he helps teams develop and control drug-device combination products by aligning quality systems, development, and regulatory expectations across drug and device domains. He is a consultant, auditor, trainer, and speaker with experience across Pfizer, Gilead, and Baxter, supporting the development and launch of combination products across vaccines, biologics, and generics.

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(245)

209 - ALCOA++ EXPLAINED | What Everyone Gets Wrong About Data Integrity with Monika Andraos

209 - ALCOA++ EXPLAINED | What Everyone Gets Wrong About Data Integrity with Monika Andraos

In this episode, I talk with Monika Andraos of Dunamis Compliance about how organizations can navigate group think and approach data integrity the right way. We cover risk culture, CSV vs. data integr...

8 Loka 202522min

208 - How Drugs Are Designed, Targets, Phenotypes, and Structure Based Design

208 - How Drugs Are Designed, Targets, Phenotypes, and Structure Based Design

In this episode, Jesse Gordon-Blake, PhD, delves into the intricacies of medicinal chemistry, particularly focusing on drug discovery for ALS (amyotrophic lateral sclerosis). Jesse explains the proces...

1 Loka 202528min

207 - What 99.999% Reliability Really Means

207 - What 99.999% Reliability Really Means

In this episode, Subhi Saadeh sits down with Alan Stevens, CAPT, to break down the concept of five nines (99.999% reliability) in medical devices. They cover where the standard came from, why FDA intr...

24 Syys 202523min

206 - Will AI Decide Your Next Drug/Device Approval?

206 - Will AI Decide Your Next Drug/Device Approval?

Artificial Intelligence is moving fast but how do you regulate it in industries where precision and risk management are everything?In this episode of Let’s Combinate, Subhi Saadeh sits down with Domin...

17 Syys 202531min

205 - Why Less Than 20% of Companies Have Started Quality 4.0

205 - Why Less Than 20% of Companies Have Started Quality 4.0

Nearly two-thirds of companies believe Quality 4.0 will transform their operations in the next five years yet fewer than 20% have started, and most haven’t even reached the planning stage. In this con...

11 Syys 202535min

204 - The Dictionary & Thesaurus of Combination Products (Finally Explained) with Susan Neadle

204 - The Dictionary & Thesaurus of Combination Products (Finally Explained) with Susan Neadle

In this episode of Let’s ComBinate: Drugs + Devices, we welcome back Susan Neadle, author of The Combination Products Handbook. Susan explores the persistent and evolving challenge of terminology in c...

3 Syys 202532min

203 - Drug Delivery, Platforms, IP Battles, Supply Chain Risks with Jim Collins

203 - Drug Delivery, Platforms, IP Battles, Supply Chain Risks with Jim Collins

In this episode of Let’s Combinate, Subhi Saadeh sits down with Jim Collins, a leader in drug delivery with over 30 years of experience at Eli Lilly, Sanofi, and now as an advisor and board member. Ji...

27 Elo 202545min

202 - Becoming an Expert in the Work Nobody Wants to Do/Design, Risk, and the Messy Middle of Combination Products w/Joey Frechin

202 - Becoming an Expert in the Work Nobody Wants to Do/Design, Risk, and the Messy Middle of Combination Products w/Joey Frechin

In this episode of Let's Combinate, host Subhi Saadeh is joined by long-time friend and Senior Technical Program Manager Joey Frechin, who brings a wealth of experience in med tech consulting. They di...

20 Elo 202532min

Suosittua kategoriassa Tiede

rss-mita-tulisi-tietaa
rss-poliisin-mieli
tiedekulma-podcast
rss-tiedetta-vai-tarinaa
utelias-mieli
docemilia
sotataidon-ytimessa
filocast-filosofian-perusteet
menologeja-tutkimusmatka-vaihdevuosiin
rss-bios-podcast
rss-ranskaa-raakana
rss-duodecim-lehti
rss-duokkari-ekstra
rss-astetta-parempi-elama-podcast
rss-metsantuntijat-podcast
rss-ilmasto-kriisissa
rss-ylistys-elaimille
rss-sosiopodi